Alignment Healthcare, Inc. (ALHC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALHC SEC filings page.
Alignment Healthcare, Inc. (ALHC) reported $4.6B in revenue over the twelve months to Jun 30, 2026, up 37.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale is converting a multi-year operating deficit into near break-even results and positive cash flow despite a still-leveraged balance sheet.
From FY2023 to FY2025, revenue more than doubled while operating margin improved from-7.0% to0.4% , a pattern consistent with fixed-cost absorption as the business expanded. Operating cash flow swung from-$59.2M in FY2023 to$139.9M in FY2025 while net income was still slightly negative, indicating cash conversion improved alongside reported earnings rather than being purely accounting-driven.
Debt-to-equity peaked at 3.2x in FY2024 before easing to 1.8x in FY2025, so improved profitability did not come solely from reducing leverage. The current ratio fell from 3.3x in FY2021 to 1.7x in FY2025, leaving less short-term balance-sheet cushion.
Free cash flow moved from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Alignment Healthcare, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Alignment Healthcare, Inc. has an operating margin of 0.4%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 33/100, indicating healthy but not exceptional operating efficiency. This is up from -3.8% the prior year.
Alignment Healthcare, Inc.'s revenue surged 46.1% year-over-year to $3.9B, reflecting rapid business expansion. This strong growth earns a score of 95/100.
Alignment Healthcare, Inc. carries a low D/E ratio of 1.80, meaning only $1.80 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.
Alignment Healthcare, Inc.'s current ratio of 1.71 indicates adequate short-term liquidity, earning a score of 50/100. The company can meet its near-term obligations, though with limited headroom.
Alignment Healthcare, Inc.'s free cash flow margin of 2.9% results in a low score of 26/100. Capital expenditures of $26.8M absorb a large share of operating cash flow.
Alignment Healthcare, Inc. posts a -0.4% return on equity (ROE), meaning it loses less than $1 for every $100 of shareholders' equity. This results in a returns score of 25/100. This is up from -128.2% the prior year.
Alignment Healthcare, Inc. scores 4.64, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Alignment Healthcare, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Alignment Healthcare, Inc. reported a net loss of $724K while generating $139.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Alignment Healthcare, Inc. earns $0.93 in operating income for every $1 of interest expense ($14.8M vs $15.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Alignment Healthcare, Inc. generated $1.3B in revenue in Q2 2026. This represents an increase of 31.6% from the same quarter a year earlier. Against the prior quarter it is up 8.1%.
Alignment Healthcare, Inc.'s EBITDA was $50.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.9% from the same quarter a year earlier. Against the prior quarter it is up 114.0%.
Alignment Healthcare, Inc. reported $36.6M in net income in Q2 2026. This represents an increase of 133.4% from the same quarter a year earlier. Against the prior quarter it is up 220.3%.
Alignment Healthcare, Inc. earned $0.17 per diluted share (EPS) in Q2 2026. This represents an increase of 142.9% from the same quarter a year earlier. Against the prior quarter it is up 240.0%.
Cash & Balance Sheet
Alignment Healthcare, Inc. recorded an outflow of $27.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 230.0% from the same quarter a year earlier. Against the prior quarter it is down 122.6%.
Alignment Healthcare, Inc. held $693.5M in cash against $324.1M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Alignment Healthcare, Inc.'s operating margin was 3.1% in Q2 2026, reflecting core business profitability. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Alignment Healthcare, Inc.'s net profit margin was 2.7% in Q2 2026, showing the share of revenue converted to profit. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.
Alignment Healthcare, Inc.'s ROE was 13.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.3 percentage points.
Not reported for Q2 2026.
Capital Allocation
Alignment Healthcare, Inc. invested $10.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 26.8% from the same quarter a year earlier. Against the prior quarter it is up 37.8%.
Not reported for Q2 2026.
Not reported for Q2 2026.
ALHC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B+31.6% | $1.2B+33.3% | $1.0B+44.4% | $993.7M+43.5% | $1.0B+49.0% | $926.9M+47.5% | $701.2M+50.7% | $692.4M+51.6% |
| SG&A Expenses | $131.0M+26.2% | $121.1M+16.7% | $125.8M+23.1% | $110.0M+21.1% | $103.8M+18.1% | $103.8M+14.7% | $102.1M+22.0% | $90.9M+9.4% |
| Operating Income | $42.1M+85.1% | $15.5M+387.5% | -$10.3M+54.4% | $7.7M+139.3% | $22.7M+223.8% | -$5.4M+86.9% | -$22.5M+46.2% | -$19.5M+34.4% |
| EBITDA | $50.0M+67.9% | $23.3M+960.5% | -$2.5M+84.5% | $15.7M+231.8% | $29.8M+350.2% | $2.2M+106.3% | -$15.8M+56.3% | -$11.9M+51.0% |
| Interest Expense | $4.3M+8.2% | $4.1M+2.8% | $3.9M-28.1% | $4.0M-43.1% | $4.0M-30.6% | $4.0M-27.2% | $5.5M+0.1% | $6.9M+26.9% |
| Income Tax | $1.3M-60.7% | $25K+19.0% | -$3.2M-46200.0% | $2K+125.0% | $3.2M+14554.5% | $21K | $7K+129.2% | -$8K |
| Net Income | $36.6M+133.4% | $11.4M+225.3% | -$11.0M+64.6% | $3.7M+114.1% | $15.7M+165.3% | -$9.1M+80.4% | -$31.1M+34.1% | -$26.4M+24.6% |
| EPS (Basic) | $0.18+125.0% | $0.06+220.0% | -$0.05+68.8% | $0.02+114.3% | $0.08+161.5% | -$0.05+80.0% | -$0.16+36.0% | -$0.14+26.3% |
| EPS (Diluted) | $0.17+142.9% | $0.05+200.0% | -$0.05+68.8% | $0.02+114.3% | $0.07+153.8% | -$0.05+80.0% | -$0.16+36.0% | -$0.14+26.3% |
| Diluted Shares (Avg) | 215M+2.6% | 213M+10.1% | N/A | 209M+9.2% | 210M+9.8% | 194M+2.4% | N/A | 191M+2.2% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
ALHC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B+27.9% | $1.3B+40.9% | $1.1B+36.3% | $1.1B+59.3% | $1.0B+39.6% | $895.6M+41.4% | $782.1M+32.1% | $692.3M-10.2% |
| Current Assets | $1.2B+31.9% | $1.1B+47.9% | $951.6M+43.8% | $985.3M+71.8% | $880.1M+46.9% | $774.5M+48.8% | $661.6M+36.8% | $573.6M-14.0% |
| Cash & Equivalents | $693.5M+47.5% | $705.6M+58.1% | $575.8M+33.0% | $618.1M+81.6% | $470.3M+38.7% | $446.2M+86.8% | $432.9M+113.3% | $340.3M-13.1% |
| Short-Term Investments | $8.3M-75.4% | $20.7M-37.9% | $28.4M-24.8% | $26.0M-36.0% | $33.5M+35.7% | $33.4M-46.9% | $37.8M-67.4% | $40.7M-67.2% |
| Accounts Receivable | $296.9M+4.9% | $277.7M+29.7% | $253.2M+64.5% | $219.8M+58.3% | $282.9M+54.4% | $214.1M+29.7% | $153.9M+28.5% | $138.9M+31.6% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $32.1M0.0% | $32.1M-6.2% | $32.1M-7.9% | $32.1M-7.9% | $32.1M-7.9% | $34.2M-1.8% | $34.8M0.0% | $34.8M0.0% |
| Total Liabilities | $1.0B+18.0% | $1.1B+34.1% | $886.5M+30.2% | $940.7M+63.1% | $859.2M+45.3% | $786.6M+56.9% | $681.1M+57.0% | $576.7M-0.8% |
| Current Liabilities | $683.4M+29.1% | $724.8M+58.5% | $556.9M+58.3% | $611.1M+70.7% | $529.5M+42.5% | $457.1M+38.2% | $351.8M+33.8% | $358.1M-12.7% |
| Non-Current Liabilities | $330.5M+0.3% | $330.0M+0.1% | $329.6M+0.1% | $329.7M+50.8% | $329.7M+49.9% | $329.5M+93.3% | $329.3M+92.8% | $218.6M+27.9% |
| Long-Term Debt | $324.1M+0.5% | $323.6M+0.5% | $323.2M+0.5% | $322.7M+53.4% | $322.3M+52.2% | $321.9M+98.6% | $321.4M+98.6% | $210.4M+30.2% |
| Total Equity | $265.1M+88.1% | $206.9M+91.3% | $179.3M+79.5% | $161.9M+41.3% | $141.0M+14.0% | $108.1M-17.4% | $99.9M-36.4% | $114.5M-39.2% |
| Retained Earnings | -$961.0M+4.1% | -$997.6M+1.9% | -$1.0B-0.1% | -$998.0M-2.1% | -$1.0B-5.4% | -$1.0B-9.8% | -$1.0B-14.5% | -$977.2M-17.3% |
Not reported in any period shown, so not listed: Inventory.
ALHC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$17.3M-159.4% | $128.7M+674.4% | -$50.4M-478.3% | $144.6M+452.0% | $29.1M+23.8% | $16.6M+366.4% | -$8.7M+95.4% | $26.2M+337.1% |
| Depreciation & Amortization | $7.9M+12.2% | $7.8M+3.2% | $7.8M+15.8% | $8.0M+4.4% | $7.0M+7.9% | $7.6M+27.1% | $6.8M+16.6% | $7.6M+39.0% |
| Stock-Based Compensation | $18.2M+16.9% | $14.0M-18.4% | N/A | $16.2M-6.0% | $15.6M-7.3% | $17.2M-17.6% | N/A | $17.3M+27.2% |
| Capital Expenditures | $10.1M+26.8% | $7.4M-10.8% | $5.0M-45.8% | $5.5M-40.8% | $8.0M-31.8% | $8.3M-25.8% | $9.3M-12.4% | $9.3M-2.9% |
| Free Cash Flow | -$27.5M-230.0% | $121.3M+1350.5% | -$55.4M-207.9% | $139.1M+722.3% | $21.1M+79.1% | $8.4M+148.2% | -$18.0M+90.9% | $16.9M+574.9% |
| Investing Cash Flow | $2.4M+136.3% | $578K+116.7% | -$7.2M-21.0% | $2.3M+109.4% | -$6.7M-124.7% | -$3.5M-108.1% | -$5.9M-481.5% | -$24.6M-155.6% |
| Financing Cash Flow | $2.8M+71.6% | $515K+184.5% | $15.3M-85.7% | $948K | $1.6M-96.7% | $181K+154.0% | $106.9M+237400.0% | $0 |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ALHC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.1%+0.9pp | 1.3%+1.8pp | -1.0%+2.2pp | 0.8%+3.6pp | 2.2%+4.9pp | -0.6%+6.0pp | -3.2%+5.8pp | -2.8%+3.7pp |
| Net Margin | 2.7%+1.2pp | 0.9%+1.9pp | -1.1%+3.3pp | 0.4%+4.2pp | 1.5%+5.1pp | -1.0%+6.4pp | -4.4%+5.7pp | -3.8%+3.9pp |
| Return on Equity | 13.8%+2.7pp | 5.5%+14.0pp | -6.1%+25.0pp | 2.3%+25.4pp | 11.1%+30.5pp | -8.4%+27.1pp | -31.1%-1.1pp | -23.1%-4.5pp |
| Return on Assets | 2.9%+1.3pp | 0.9%+1.9pp | -1.0%+3.0pp | 0.3%+4.2pp | 1.6%+4.9pp | -1.0%+6.3pp | -4.0%+4.0pp | -3.8%+0.7pp |
| Current Ratio | 1.700.0x | 1.58-0.1x | 1.71-0.2x | 1.610.0x | 1.660.0x | 1.69+0.1x | 1.880.0x | 1.600.0x |
| Debt-to-Equity | 1.22-1.1x | 1.56-1.4x | 1.80-1.4x | 1.99+0.2x | 2.29+0.6x | 2.98+1.7x | 3.22+2.2x | 1.84+1.0x |
| Asset Turnover | 1.040.0x | 0.98-0.1x | 0.95+0.1x | 0.90-0.1x | 1.02+0.1x | 1.030.0x | 0.90+0.1x | 1.00+0.4x |
| FCF Margin | -2.1%-4.1pp | 9.8%+8.9pp | -5.5%-2.9pp | 14.0%+11.5pp | 2.1%+0.3pp | 0.9%+3.7pp | -2.6%+40.0pp | 2.4%+3.2pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Alignment Healthcare, Inc. ALHC | FY2025 | $3.9B | -$724K | 0.0% | $2.6B | 55/100 |
| Oscar Health, Inc. OSCR | FY2025 | $11.7B | -$443.2M | -3.8% | $10.1B | 46/100 |
| Progyny, Inc. PGNY | FY2025 | $1.3B | $58.5M | 4.5% | $2.1B | 70/100 |
| Clover Health Investments, Corp CLOV | FY2025 | $1.9B | -$85.5M | -4.5% | $2.6B | 41/100 |
| Molina Healthcare, Inc. MOH | FY2025 | $45.4B | $472.0M | 1.0% | $10.7B | 63/100 |
| CVS Health Corporation CVS | FY2025 | $402.1B | $1.8B | 0.4% | $121.1B | 35/100 |
Where Alignment Healthcare, Inc. Ranks
Frequently Asked Questions
What is Alignment Healthcare, Inc.'s annual revenue?
Alignment Healthcare, Inc. (ALHC) reported $3.9B in total revenue for fiscal year 2025. This represents a 46.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Alignment Healthcare, Inc.'s revenue growing?
Alignment Healthcare, Inc. (ALHC) revenue grew by 46.1% year-over-year, from $2.7B to $3.9B in fiscal year 2025.
Is Alignment Healthcare, Inc. profitable?
No, Alignment Healthcare, Inc. (ALHC) reported a net income of -$724K in fiscal year 2025, with a net profit margin of 0.0%.
What is Alignment Healthcare, Inc.'s EBITDA?
Alignment Healthcare, Inc. (ALHC) had EBITDA of $45.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Alignment Healthcare, Inc. have?
As of fiscal year 2025, Alignment Healthcare, Inc. (ALHC) had $575.8M in cash and equivalents against $323.2M in long-term debt.
What is Alignment Healthcare, Inc.'s operating margin?
Alignment Healthcare, Inc. (ALHC) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Alignment Healthcare, Inc.'s net profit margin?
Alignment Healthcare, Inc. (ALHC) had a net profit margin of 0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Alignment Healthcare, Inc.'s return on equity (ROE)?
Alignment Healthcare, Inc. (ALHC) has a return on equity of -0.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Alignment Healthcare, Inc.'s free cash flow?
Alignment Healthcare, Inc. (ALHC) generated $113.1M in free cash flow during fiscal year 2025. This represents a 1802.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alignment Healthcare, Inc.'s operating cash flow?
Alignment Healthcare, Inc. (ALHC) generated $139.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Alignment Healthcare, Inc.'s total assets?
Alignment Healthcare, Inc. (ALHC) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alignment Healthcare, Inc.'s capital expenditures?
Alignment Healthcare, Inc. (ALHC) invested $26.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Alignment Healthcare, Inc.'s current ratio?
Alignment Healthcare, Inc. (ALHC) had a current ratio of 1.71 as of fiscal year 2025, which is generally considered healthy.
What is Alignment Healthcare, Inc.'s debt-to-equity ratio?
Alignment Healthcare, Inc. (ALHC) had a debt-to-equity ratio of 1.80 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Alignment Healthcare, Inc.'s return on assets (ROA)?
Alignment Healthcare, Inc. (ALHC) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Alignment Healthcare, Inc.'s P/E ratio?
Alignment Healthcare, Inc. (ALHC) trades at 64.3x earnings, its market capitalization divided by net income of $40.7M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.6B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alignment Healthcare, Inc.'s price-to-sales ratio?
Alignment Healthcare, Inc. (ALHC) trades at 0.6x sales, its market capitalization divided by revenue of $4.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.6B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Alignment Healthcare, Inc.'s Altman Z-Score?
Alignment Healthcare, Inc. (ALHC) has an Altman Z-Score of 4.64, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Alignment Healthcare, Inc.'s Piotroski F-Score?
Alignment Healthcare, Inc. (ALHC) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alignment Healthcare, Inc.'s earnings high quality?
Alignment Healthcare, Inc. (ALHC) reported a net loss of $724K while generating $139.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Alignment Healthcare, Inc. cover its interest payments?
Alignment Healthcare, Inc. (ALHC) has an interest coverage ratio of 0.93x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Alignment Healthcare, Inc.?
Alignment Healthcare, Inc. (ALHC) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.